Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHSE: 688806)
Health Care · Biotechnology · CN
CN¥21.97
-5.02% today · -51.3% 1Y
Public summary
A free snapshot of Zhuhai Trinomab Pharmaceutical Co., Ltd., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHSE: 688806) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.52B.
Over the last twelve months the share price has lost 51.3%, trading between 19.84 and 52.52.
Tweenvest scores Zhuhai Trinomab Pharmaceutical Co., Ltd. across four factors: quality 30/100, value 76/100. Its strongest factor is value.
688806 price history
Key figures
- Market cap
- $1.52B
- Revenue (TTM)
- $26.14M
- P/E
- -18.12
- EPS
- -1.56
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- CN¥52.52
- 52-week low
- CN¥19.84
- Avg volume (3M)
- —
- Shares outstanding
- 460.55M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Mesoblast LimitedASX: MSB | $1.53B | AU$1.76 | -1.95% |
| Vitrolife AB (publ)OM: VITR | $1.53B | Skr117.40 | -0.25% |
| Kailera Therapeutics, Inc.NasdaqGS: KLRA | $1.53B | $11.79 | -3.36% |
| TLC BioSciences Corp.TPEX: 7924 | $1.52B | NT$375.00 | -2.47% |
| Voronoi, Inc.KOSDAQ: A310210 | $1.51B | ₩111,000.00 | +1.19% |
| CanSino Biologics Inc.SEHK: 6185 | $1.50B | HK$23.34 | -1.85% |
| AlvotechNasdaqGM: ALVO | $1.50B | $4.19 | -10.28% |
| Korsana Biosciences, Inc.NasdaqCM: KRSA | $1.49B | $32.68 | +3.25% |